These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 27652916

  • 1. ELECTRORETINOGRAPHIC AND VISUAL-EVOKED POTENTIAL CHANGES IN RELATION TO CHELATION MODALITY IN CHILDREN WITH THALASSEMIA.
    El-Shazly AA, Ebeid WM, Elkitkat RS, Deghedy MR.
    Retina; 2017 Jun; 37(6):1168-1175. PubMed ID: 27652916
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients.
    Dettoraki M, Kattamis A, Ladas I, Maragkos K, Koutsandrea C, Chatzistefanou K, Laios K, Brouzas D, Moschos MM.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1349-1358. PubMed ID: 28361176
    [Abstract] [Full Text] [Related]

  • 3. Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease.
    Krasodomska K, Lubiński W, Potemkowski A, Honczarenko K.
    Doc Ophthalmol; 2010 Oct; 121(2):111-21. PubMed ID: 20549299
    [Abstract] [Full Text] [Related]

  • 4. Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major.
    Gelmi C, Borgna-Pignatti C, Franchin S, Tacchini M, Trimarchi F.
    Ophthalmologica; 1988 Oct; 196(1):29-34. PubMed ID: 3347468
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources.
    Arandi N, Haghpanah S, Safaei S, Zahedi Z, Ashrafi A, Eatemadfar P, Zarei T, Radwan AH, Taher AT, Karimi M.
    Transfus Med; 2015 Feb; 25(1):8-12. PubMed ID: 25801075
    [Abstract] [Full Text] [Related]

  • 6. The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.
    Lachowicz E, Lubiński W.
    Doc Ophthalmol; 2018 Dec; 137(3):193-202. PubMed ID: 30374652
    [Abstract] [Full Text] [Related]

  • 7. Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia.
    Haghpanah S, Zarei T, Zahedi Z, Karimi M.
    Hematology; 2014 Jun; 19(4):187-91. PubMed ID: 24074344
    [Abstract] [Full Text] [Related]

  • 8. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
    Piga A, Galanello R, Forni GL, Cappellini MD, Origa R, Zappu A, Donato G, Bordone E, Lavagetto A, Zanaboni L, Sechaud R, Hewson N, Ford JM, Opitz H, Alberti D.
    Haematologica; 2006 Jul; 91(7):873-80. PubMed ID: 16818273
    [Abstract] [Full Text] [Related]

  • 9. Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.
    Moschos MM, Chatziralli IP, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos G.
    Cutan Ocul Toxicol; 2016 Mar; 35(1):13-20. PubMed ID: 25597370
    [Abstract] [Full Text] [Related]

  • 10. Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry.
    Fischer R, Piga A, Harmatz P, Nielsen P.
    Ann N Y Acad Sci; 2005 Mar; 1054():350-7. PubMed ID: 16339683
    [Abstract] [Full Text] [Related]

  • 11. Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature.
    Georgakopoulos CD, Tsapardoni F, Kostopoulou EV, Makri OE.
    BMC Ophthalmol; 2018 Sep 12; 18(1):246. PubMed ID: 30208862
    [Abstract] [Full Text] [Related]

  • 12. Multifocal electroretinogram in multiple evanescent white dot syndrome.
    Huang HJ, Yamazaki H, Kawabata H, Ninomiya T, Adachi-Usami E.
    Doc Ophthalmol; 2018 Sep 12; 92(4):301-9. PubMed ID: 9476597
    [Abstract] [Full Text] [Related]

  • 13. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V, Miglior S, Manni G, Centofanti M, Bucci MG.
    Ophthalmology; 2006 Feb 12; 113(2):216-28. PubMed ID: 16406535
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.
    Elalfy MS, Adly AM, Wali Y, Tony S, Samir A, Elhenawy YI.
    Eur J Haematol; 2015 Nov 12; 95(5):411-20. PubMed ID: 25600572
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ophthalmic Evaluation in Beta-Thalassemia.
    Merchant RH, Punde H, Thacker N, Bhatt D.
    Indian J Pediatr; 2017 Jul 12; 84(7):509-514. PubMed ID: 28367614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversible retinopathy associated with oral deferasirox therapy.
    Walia HS, Yan J.
    BMJ Case Rep; 2013 Jul 17; 2013():. PubMed ID: 23867877
    [Abstract] [Full Text] [Related]

  • 20. Electroretinogram and visual-evoked potentials in children with optic nerve coloboma.
    Tormene AP, Riva C.
    Doc Ophthalmol; 2013 Jul 17; 96(4):347-54. PubMed ID: 10855810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.